Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Taiwanese (TAIEX) Biotech Industry Analysis

UpdatedDec 30, 2024
DataAggregated Company Financials
Companies65
  • 7D4.5%
  • 3M-7.3%
  • 1Y2.6%
  • YTD1.8%

The Biotech industry is up 4.5% in the last week, with PharmaEssentia up 6.7%. Despite this gain, the industry's performance has been flat over the past year. As for the next few years, earnings are expected to grow by 64% per annum.

Industry Valuation and Performance

Has the Taiwanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 30 Dec 2024NT$512.6bNT$24.8b-NT$10,902,841,000.0034.3x-47x20.7x
Wed, 27 Nov 2024NT$514.0bNT$24.8b-NT$10,782,551,000.0038.2x-47.7x20.8x
Fri, 25 Oct 2024NT$544.2bNT$23.5b-NT$10,829,095,000.0039.4x-50.2x23.2x
Sun, 22 Sep 2024NT$579.7bNT$23.5b-NT$10,829,095,000.0035x-53.5x24.7x
Tue, 20 Aug 2024NT$557.2bNT$23.6b-NT$10,755,142,000.0033.8x-51.8x23.7x
Thu, 18 Jul 2024NT$579.8bNT$21.9b-NT$11,110,643,000.0044.1x-52.2x26.4x
Sat, 15 Jun 2024NT$513.1bNT$21.9b-NT$11,110,643,000.0042.7x-46.2x23.4x
Mon, 13 May 2024NT$454.9bNT$21.0b-NT$12,438,653,000.0034.2x-36.6x21.7x
Wed, 10 Apr 2024NT$462.1bNT$21.1b-NT$11,584,268,000.0051.1x-39.9x21.9x
Fri, 08 Mar 2024NT$445.0bNT$20.7b-NT$9,881,281,000.0039.7x-45x21.4x
Sun, 04 Feb 2024NT$435.3bNT$19.9b-NT$9,830,596,000.0039.3x-44.3x21.9x
Tue, 02 Jan 2024NT$472.2bNT$19.8b-NT$9,748,146,000.0039.5x-48.4x23.9x
Thu, 30 Nov 2023NT$482.7bNT$19.9b-NT$9,817,316,000.0042.8x-49.2x24.3x
Sat, 28 Oct 2023NT$472.4bNT$18.4b-NT$10,823,013,000.0051.5x-43.6x25.6x
Mon, 25 Sep 2023NT$476.6bNT$18.3b-NT$10,776,417,000.0042.6x-44.2x26x
Wed, 23 Aug 2023NT$488.2bNT$18.2b-NT$10,711,380,000.0042.3x-45.6x26.8x
Fri, 21 Jul 2023NT$489.4bNT$18.7b-NT$10,724,655,000.0047.8x-45.6x26.2x
Sun, 18 Jun 2023NT$482.0bNT$18.7b-NT$10,709,428,000.0042.7x-45x25.8x
Tue, 16 May 2023NT$487.0bNT$18.6b-NT$9,763,193,000.0045.1x-49.9x26.1x
Thu, 13 Apr 2023NT$513.5bNT$18.5b-NT$9,600,625,000.0042.8x-53.5x27.8x
Sat, 11 Mar 2023NT$510.5bNT$22.3b-NT$7,221,244,000.0037.4x-70.7x22.9x
Mon, 06 Feb 2023NT$533.2bNT$21.8b-NT$7,778,690,000.0037.8x-68.5x24.4x
Wed, 04 Jan 2023NT$491.2bNT$21.8b-NT$7,778,690,000.0037.1x-63.2x22.5x
Fri, 02 Dec 2022NT$522.7bNT$21.8b-NT$7,522,211,000.0041.8x-69.5x24x
Sun, 30 Oct 2022NT$434.1bNT$23.1b-NT$6,633,590,000.0034.3x-65.4x18.8x
Tue, 27 Sep 2022NT$579.1bNT$23.1b-NT$6,633,590,000.0039.8x-87.3x25.1x
Thu, 25 Aug 2022NT$605.4bNT$23.0b-NT$6,443,294,000.0040.8x-94x26.3x
Sat, 23 Jul 2022NT$531.4bNT$22.5b-NT$5,642,821,000.0029.8x-94.2x23.6x
Mon, 20 Jun 2022NT$523.2bNT$22.5b-NT$5,642,821,000.0032.9x-92.7x23.2x
Wed, 18 May 2022NT$500.0bNT$22.0b-NT$5,852,748,000.0032.3x-85.4x22.7x
Fri, 15 Apr 2022NT$542.8bNT$21.5b-NT$5,766,469,000.0033.7x-94.1x25.3x
Sun, 13 Mar 2022NT$500.7bNT$18.0b-NT$5,714,604,000.0026.3x-87.6x27.8x
Tue, 08 Feb 2022NT$447.3bNT$17.9b-NT$5,532,702,000.0025.5x-80.9x25x
Thu, 06 Jan 2022NT$440.9bNT$17.9b-NT$5,532,702,000.0026x-79.7x24.6x
Price to Earnings Ratio

-79.7x


Total Market Cap: NT$440.9bTotal Earnings: -NT$5,532,702,000.00Total Revenue: NT$17.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Biotech Industry Price to Earnings3Y Average -61.4x20232024
Current Industry PE
  • Investors are pessimistic on the Taiwanese Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 24.0x is higher than the industry's current PS ratio of 20.7x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 11% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market3.20%
Healthcare3.27%
Biotech4.50%
Biotech4.50%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6446 PharmaEssentiaNT$602.002.0%
+NT$4.0b		74.0%PE108.4x
6808 3D Global BiotechNT$62.2023.2%
+NT$898.7m		219.8%PS86.6x
4147 TaiMed BiologicsNT$85.503.1%
+NT$710.0m		4.3%PS37.5x
4162 PharmaEngineNT$91.004.6%
+NT$574.7m		-13.7%PE35.3x
6541 Tanvex BioPharmaNT$63.503.9%
+NT$393.8m		-2.5%PS254.4x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6645

NT$23.90

Kim Forest Enterprise

7D

-7.9%

1Y

-32.0%

6446

NT$602.00

PharmaEssentia

7D

2.0%

1Y

74.0%

Does PharmaEssentia (TWSE:6446) Have A Healthy Balance Sheet?

Dec 18
Does PharmaEssentia (TWSE:6446) Have A Healthy Balance Sheet?

6885

NT$30.80

BRIM Biotechnology

7D

-3.1%

1Y

2.8%

4162

NT$91.00

PharmaEngine

7D

4.6%

1Y

-13.7%

4157

NT$11.30

TaiGen Biopharmaceuticals Holdings

7D

4.1%

1Y

-25.7%

4726

NT$43.15

Mycenax Biotech

7D

-1.4%

1Y

20.9%

4174

NT$56.60

OBI Pharma

7D

-0.9%

1Y

-18.4%

6875

NT$52.80

Pharmosa Biopharm

7D

-1.7%

1Y

-40.0%

6617

NT$112.50

Gongwin Biopharm Holdings

7D

-0.4%

1Y

-39.0%

4147

NT$85.50

TaiMed Biologics

7D

3.1%

1Y

4.3%

6550

NT$45.05

Polaris Group

7D

1.0%

1Y

-40.4%

6541

NT$63.50

Tanvex BioPharma

7D

3.9%

1Y

-2.5%

6580

NT$26.30

TaiRx

7D

-3.0%

1Y

-2.6%

4169

NT$57.20

TCM Biotech International

7D

-1.9%

1Y

-1.7%

6955

NT$151.50

Bonraybio

7D

9.0%

1Y

102.6%

6808

NT$62.20

3D Global Biotech

7D

23.2%

1Y

219.8%